Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of transfusion-dependent congenital dyserythropoietic anemia Type I patients with pegylated interferon alpha-2a.

European journal of haematology - 1 Aug 2020

Abu-Quider Abed, Asleh Mahdi, Shalev Hanna, Fruchtman Yariv, Ben-Harosh Meriam, Beck Guy, Kapelushnik Josef

Abstract excerpt

OBJECTIVE: Pegylated IFN-α2a has been reported in two case reports as being efficacious in treating CDA-I patients. This study aims to assess its efficacy on a series of CDA-I patients. METHODS: Study sample consisted of seven CDA type 1 transfusion-dependent patients. They received pegylated interferon alpha-2a at an initial dose of 90-180 µg once a week, tapered according to clinical response and side effects....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Dyserythropoietic, Congenital
Share to Blood Transfusion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Disease Management

Share to Erythrocyte Indices

Share to Interferon-alpha

Share to Iron Overload

Share to Polyethylene Glycols

Source

Identifiers

PMID: 32302424
DOI: 10.1111/ejh.13428

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of transfusion-dependent congenital dyserythropoietic anemia Type I patients with pegylated interferon alpha-2a.PMID 32302424Read ↗

Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.Semantic proximity Read ↗

Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).Semantic proximity Read ↗

The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type ISemantic proximity Read ↗

Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.Semantic proximity Read ↗

Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation.Semantic proximity Read ↗

Congenital dyserythropoietic anemias.Semantic proximity Read ↗

Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults.Semantic proximity Read ↗

A case of congenital dyserythropoietic anemia type IVSemantic proximity Read ↗

Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.Semantic proximity Read ↗

[Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].Semantic proximity Read ↗

Congenital dyserythropoietic anemias: III's a charm.Semantic proximity Read ↗

Fetal-onset Congenital Dyserythropoietic Anemia Type 1 due to a Novel Mutation With Severe Iron Overload and Severe Cholestatic Liver Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.